BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 885572)

  • 1. Evolution of cell-mediated immunity in mice bearing solid sarcoma 180.
    Chakraborti RN; Sarkar RK; Patra G
    Indian J Cancer; 1977 Mar; 14(1):75-80. PubMed ID: 885572
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the tumor-bearing host serum on the leukocyte adherence inhibition reaction mediated by immune RNA].
    Wang XM; Wang CJ; Su CZ
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):106-8. PubMed ID: 2443326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen driven selection for Fc receptors of enhancing antibody on macrophages during an alloimmune response.
    Whitten HD; Cruse JM; Lewis GK; Watson ES
    J Reticuloendothel Soc; 1974 Feb; 15(2):118-25. PubMed ID: 4815211
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of local cellular reaction to tumor grafts in mice treated with some plant polysaccharides.
    Tokuzen R
    Cancer Res; 1971 Nov; 31(11):1590-3. PubMed ID: 5121662
    [No Abstract]   [Full Text] [Related]  

  • 5. Macrophage activities in sarcoma 180-bearing mice and EL4-bearing mice.
    Kurashige S; Mitsuhashi S
    Gan; 1982 Feb; 73(1):85-90. PubMed ID: 6749590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo.
    Deodhar SD; Lee VW; Chiang T; Mahmoud AF; Watten KS
    Cancer Res; 1976 Sep; 36(9 pt.1):3147-50. PubMed ID: 975080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic inhibition in tolerant animals.
    Möller E; Lapp W; Lindholm L
    Transplant Proc; 1969 Mar; 1(1):543-7. PubMed ID: 4944269
    [No Abstract]   [Full Text] [Related]  

  • 8. Active immunological enhancement of sarcoma 180 in splenectomized Swiss mice.
    Dosne Pasqualini C; Colmerauer ME
    Biomedicine; 1976 Jul; 25(6):202-4. PubMed ID: 963183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of spontaneous regression of Crocker sarcoma on increase of antitumor immunity.
    Harlozińska A; Stelmachowska A
    Acta Med Pol; 1969; 10(3):310-4. PubMed ID: 5824820
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cell-mediated immunity in mice infected with Japanese encephalitis virus. I. Demonstration of cell-mediated immunity in vitro with macrophage migration and leukocyte adherence inhibition tests].
    Jia FL; Huang ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Feb; 5(1):64-7. PubMed ID: 6313236
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer immunity after treatment of Ehrlich tumor with diphtheria toxin.
    Buzzi S; Buzzi L
    Cancer Res; 1974 Dec; 34(12):3481-6. PubMed ID: 4429964
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
    Halliday WJ; Koppi TA; McKenzie IF
    J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 15. Central inhibition of cellular immunity to leukemia L1210 by isoantibody.
    Mitchell MS
    Cancer Res; 1972 Apr; 32(4):825-31. PubMed ID: 4622583
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunoregulatory effects of ascites of tumor-bearing mice].
    Jia FL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):426-9. PubMed ID: 2978399
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic activity of lymphocytes. 3. Standardization of measurement of cell-mediated lysis.
    Lucas ZJ; Walker SM
    J Immunol; 1974 Jul; 113(1):209-24. PubMed ID: 4598888
    [No Abstract]   [Full Text] [Related]  

  • 18. Periodical consideration on the establishment of antitumor action in host and activation of peritoneal exudate cells by lentinan.
    Maeda YY; Chihara G
    Gan; 1973 Aug; 64(4):351-7. PubMed ID: 4752371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the possible causes of decreasing NK cell activity in tumor-bearing mice. I. The number of NK cells in the spleens of tumor-bearing mice is higher than that in normal mice].
    Fu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Dec; 11(6):421-4. PubMed ID: 2534577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of genotype of host on regression of solid and ascitic forms of sarcoma 180 and effect of chemotherapy on the solid form.
    Tarnowski GS; Mountain IM; Stock CC
    Cancer Res; 1973 Aug; 33(8):1885-8. PubMed ID: 4578565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.